Sean Wieland
Stock Analyst at Piper Sandler
(1.82)
# 3,287
Out of 5,182 analysts
31
Total ratings
45.45%
Success rate
1.67%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $45.51 | +20.85% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $24.84 | +44.93% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $6.25 | +1,820.00% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $27.91 | -78.50% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $24.57 | +79.08% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $158.98 | +45.30% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $6.00 | +4,750.00% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $45.51
Upside: +20.85%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $24.84
Upside: +44.93%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $6.25
Upside: +1,820.00%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $27.91
Upside: -78.50%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $24.57
Upside: +79.08%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $158.98
Upside: +45.30%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $6.00
Upside: +4,750.00%